HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio Artigas Selected Research

MT protocol

1/2022Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio Artigas Research Topics

Disease

33Sepsis (Septicemia)
11/2021 - 03/2003
21Critical Illness (Critically Ill)
05/2022 - 05/2010
18COVID-19
05/2022 - 01/2020
17Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
03/2021 - 06/2009
13Pneumonia (Pneumonitis)
01/2022 - 06/2011
13Infections
01/2022 - 01/2006
10Ventilator-Associated Pneumonia
01/2021 - 02/2002
10Septic Shock (Toxic Shock Syndrome)
12/2018 - 11/2009
9Hemorrhage
01/2020 - 06/2003
8Acute Lung Injury
01/2020 - 08/2004
7Lung Injury
01/2022 - 06/2009
6Acute Kidney Injury (Acute Renal Failure)
10/2022 - 02/2013
6Frailty
03/2022 - 01/2019
6Inflammation (Inflammations)
09/2021 - 01/2016
5Respiratory Insufficiency (Respiratory Failure)
01/2022 - 01/2013
3Respiratory Tract Infections (Respiratory Tract Infection)
04/2022 - 01/2021
3Thrombosis (Thrombus)
01/2022 - 01/2020
3Human Influenza (Influenza)
01/2022 - 01/2021
3Wounds and Injuries (Trauma)
01/2019 - 05/2010
2Lung Diseases (Lung Disease)
04/2022 - 01/2020
2Hypoxia (Hypoxemia)
03/2021 - 03/2015
2Virus Diseases (Viral Diseases)
01/2021 - 01/2021
2Healthcare-Associated Pneumonia
01/2021 - 01/2019
2Bacterial Infections (Bacterial Infection)
12/2020 - 01/2017
2Edema (Dropsy)
01/2020 - 01/2020
2Shock
12/2018 - 04/2015
2Fibrosis (Cirrhosis)
01/2017 - 01/2016
1Heart Failure
01/2022
1Bacteremia
11/2021
1Pneumococcal Pneumonia
11/2021
1Diabetes Mellitus
01/2021
1Chronic Renal Insufficiency
01/2021
1Superinfection
12/2020
1Peritonitis
12/2020
1Body Weight (Weight, Body)
01/2020

Drug/Important Bio-Agent (IBA)

12Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 02/2002
10drotrecogin alfa activated (Xigris)FDA Link
04/2015 - 03/2003
9Biomarkers (Surrogate Marker)IBA
10/2022 - 08/2009
9Biological ProductsIBA
10/2022 - 09/2007
9Heparin (Liquaemin)FDA LinkGeneric
05/2022 - 09/2007
5AnticoagulantsIBA
05/2022 - 10/2017
5Oxygen (Dioxygen)IBA
03/2021 - 05/2011
5CytokinesIBA
01/2020 - 01/2013
3FibrinIBA
01/2022 - 01/2020
3SteroidsIBA
10/2021 - 11/2009
3Lactic Acid (Lactate)FDA LinkGeneric
08/2021 - 11/2009
3Pharmaceutical PreparationsIBA
01/2021 - 06/2003
3Thromboplastin (Tissue Factor)IBA
01/2020 - 07/2003
3Polymyxin B (Aerosporin)FDA LinkGeneric
12/2018 - 01/2013
3EndotoxinsIBA
12/2018 - 01/2013
3Interleukin-6 (Interleukin 6)IBA
11/2017 - 06/2009
2CreatinineIBA
01/2021 - 01/2021
2Insulin-Like Growth Factor Binding ProteinsIBA
01/2021 - 10/2016
2Aluminum Oxide (Sapphire)IBA
01/2021 - 02/2013
2LipopolysaccharidesIBA
12/2020 - 01/2020
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2019
2Carbon DioxideIBA
07/2019 - 03/2015
2Immunoglobulins (Immunoglobulin)IBA
01/2018 - 12/2017
2Therapeutic UsesIBA
11/2017 - 09/2013
2Protein CIBA
05/2012 - 01/2010
2TifacoginIBA
06/2011 - 07/2003
2lipoprotein-associated coagulation inhibitor (TFPI)IBA
06/2011 - 07/2003
2Hemoglobins (Hemoglobin)IBA
05/2011 - 05/2010
1HydrogelsIBA
04/2022
1Vasodilator Agents (Vasodilators)IBA
01/2022
1SolutionsIBA
01/2022
1MacrolidesIBA
11/2021
1Penicillins (Penicillin)FDA Link
11/2021
1Methotrexate (Mexate)FDA LinkGeneric
09/2021
1LigandsIBA
01/2021
1Tissue Inhibitor of MetalloproteinasesIBA
01/2021
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
01/2021
1ChemokinesIBA
01/2021
1tazobactam drug combination ceftolozaneIBA
01/2021
1AcidsIBA
12/2020
1AntithrombinsIBA
01/2020
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2020
1CoagulantsIBA
01/2020
1Expectorants (Mucolytics)IBA
01/2020
1Fibrinogen (Factor I)FDA Link
01/2020
1Hydrochloric Acid (Hydrogen Chloride)FDA Link
01/2020
1InterleukinsIBA
01/2020

Therapy/Procedure

19Therapeutics
01/2022 - 01/2006
15Artificial Respiration (Mechanical Ventilation)
01/2022 - 08/2004
11Critical Care (Surgical Intensive Care)
03/2022 - 11/2017
7Mechanical Ventilators (Ventilator)
04/2022 - 08/2004
6Resuscitation
03/2015 - 05/2008
2Activities of Daily Living (ADL)
03/2022 - 01/2022
2Ligation
09/2021 - 12/2020
2Punctures
09/2021 - 12/2020
2Precision Medicine
03/2021 - 01/2018
2Renal Replacement Therapy (Therapies, Renal Replacement)
05/2020 - 01/2019
2Hemoperfusion
12/2018 - 12/2016
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
10/2018 - 08/2008
2Extracorporeal Membrane Oxygenation
09/2018 - 12/2017
1MT protocol
01/2022
1Tracheostomy
01/2022
1Terminal Care (Care, Terminal)
01/2022
1Complementary Therapies (Alternative Medicine)
11/2021
1Polypharmacy
01/2020